Helicobacter pylori
diagnostic tests
gastrointestinal endoscopy
histology
urea breath test
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
28 Jun 2023
28 Jun 2023
Historique:
received:
31
05
2023
revised:
15
06
2023
accepted:
21
06
2023
medline:
14
7
2023
pubmed:
14
7
2023
entrez:
14
7
2023
Statut:
epublish
Résumé
Several methods are available to diagnose The European Registry on the management of A total of 34,920 adult patients from 20 countries were included (mean age 51 years; 61% women). To establish the initial diagnosis, invasive tests were performed in 19,801 (71%) patients, non-invasive in 11,369 (41%), and both in 3437 (12%). The most frequent were histology (n = 11,885; 43%), a rapid urease test (n = 10,636; 38%) and an urea breath test (n = 7577; 27%). According to the age, invasive tests were indicated in 11,179 (77%) ≥50 years, and in 8603 (65%) <50 years. Depending on the country, the use of invasive tests ranged from 29-99% in <50 years to 60-99% in ≥50. Most of the tests used to confirm eradication were non-invasive (n = 32,540; 93%), with the urea breath test being the most frequent (n = 32,540; 78%). In 2983 (9%) post-treatment tests, histology (n = 1887; 5%) or a rapid urease test (n = 1223; 4%) were performed. A great heterogeneity was observed for the initial diagnosis and confirmation of the eradication. The reasons for the apparent lack of adherence to the clinical guidelines should be further explored.
Sections du résumé
BACKGROUND AND AIMS
OBJECTIVE
Several methods are available to diagnose
METHODS
METHODS
The European Registry on the management of
RESULTS
RESULTS
A total of 34,920 adult patients from 20 countries were included (mean age 51 years; 61% women). To establish the initial diagnosis, invasive tests were performed in 19,801 (71%) patients, non-invasive in 11,369 (41%), and both in 3437 (12%). The most frequent were histology (n = 11,885; 43%), a rapid urease test (n = 10,636; 38%) and an urea breath test (n = 7577; 27%). According to the age, invasive tests were indicated in 11,179 (77%) ≥50 years, and in 8603 (65%) <50 years. Depending on the country, the use of invasive tests ranged from 29-99% in <50 years to 60-99% in ≥50. Most of the tests used to confirm eradication were non-invasive (n = 32,540; 93%), with the urea breath test being the most frequent (n = 32,540; 78%). In 2983 (9%) post-treatment tests, histology (n = 1887; 5%) or a rapid urease test (n = 1223; 4%) were performed.
CONCLUSION
CONCLUSIONS
A great heterogeneity was observed for the initial diagnosis and confirmation of the eradication. The reasons for the apparent lack of adherence to the clinical guidelines should be further explored.
Identifiants
pubmed: 37445399
pii: jcm12134363
doi: 10.3390/jcm12134363
pmc: PMC10342434
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Clin Gastroenterol Hepatol. 2018 Jul;16(7):992-1002.e6
pubmed: 29559361
Gastroenterology. 2018 Nov;155(5):1372-1382.e17
pubmed: 29990487
Helicobacter. 2019 Oct;24(5):e12630
pubmed: 31282060
Gut. 2020 Dec;69(12):2093-2112
pubmed: 33004546
Helicobacter. 2019 Jun;24(3):e12584
pubmed: 30990575
Therap Adv Gastroenterol. 2018 Oct 30;11:1756284818805597
pubmed: 30397412
Clin Gastroenterol Hepatol. 2003 Jul;1(4):273-8
pubmed: 15017668
Clin Transl Gastroenterol. 2013 Mar 28;4:e32
pubmed: 23535826
Gastroenterol Hepatol. 2012 Dec;35(10):725.e1-38
pubmed: 23186826
Dig Dis Sci. 2014 Aug;59(8):1698-709
pubmed: 24563236
Gut. 2017 Jan;66(1):6-30
pubmed: 27707777
World J Gastroenterol. 2019 Oct 7;25(37):5578-5589
pubmed: 31602159
JAMA. 2006 Apr 5;295(13):1566-76
pubmed: 16595759
J Gastroenterol Hepatol. 2018 Jan;33(1):37-56
pubmed: 28762251
Aliment Pharmacol Ther. 2004 Nov 15;20(10):1001-17
pubmed: 15569102
Helicobacter. 2017 Sep;22 Suppl 1:
pubmed: 28891138
Am J Gastroenterol. 2006 Aug;101(8):1921-30
pubmed: 16780557
Therap Adv Gastroenterol. 2020 Nov 12;13:1756284820968736
pubmed: 33240392
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
J Clin Gastroenterol. 2022 Feb 1;56(2):e98-e108
pubmed: 33405435
Gastroenterol Hepatol. 2022 May;45(5):392-417
pubmed: 34629204
J Antimicrob Chemother. 2015 Sep;70(9):2447-55
pubmed: 26078393
Helicobacter. 2014 Sep;19 Suppl 1:1-5
pubmed: 25167938
Clin Microbiol Infect. 2013 Apr;19(4):379-83
pubmed: 22512623
Antibiotics (Basel). 2021 Sep 01;10(9):
pubmed: 34572640
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660